Delivery Order SPE2DB22D2206-SPE2DB23FFV95
Award Date 2/23/23
Potential Completion Date 3/16/23
Potential Value $108K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $41,399.91, is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, to support military treatment programs and facilities. This contract is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REVLIMID 10 MG CAPSULE 28S. This $55,719.56 contract has a completion date of March 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This award is not associated with any set-aside designation....
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $24,963.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, and has an ultimate completion date of October 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order to supply REVLIMID 15 MG CAPSULE 100S. The $105,360.34 contract is for pharmaceutical products to be delivered by May 2, 2023. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical and medical supply products and services to support DLA Troop Support Medical facilities and programs. The company also holds an...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4564060034 REVLIMID 10 MG CAPSULE 28S. The contract has a ceiling value of $13,929.89 and a performance period through April 12, 2024. This delivery order is issued under Amerisourcebergen's pre-existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $151,045.52 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply REVLIMID 10 MG CAPSULE 100S. This delivery order was issued against an existing indefinite delivery contract with the agency. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization that primarily provides pharmaceutical products and distribution services to U.S....
- This federal contract award, valued at $28,471.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, with a completion date of January 8, 2024. This is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is an established prime contractor providing a wide range of pharmaceutical...
- The Defense Logistics Agency awarded a $267,465.18 delivery order to AmerisourceBergen Drug Corp for REVLIMID 10 mg capsules (100-count units) under a firm fixed-price contract. The order, issued on May 29, 2025, is scheduled for completion by June 20, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- This is a $49,926.80 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REVLIMID 10 MG CAPSULE 28S. The contract has an ultimate completion date of August 20, 2024 and is a firm-fixed price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4557530338 - REVLIMID 5 MG CAPSULE 100S. The $160,303.95 firm fixed price delivery order contract has a completion date of July 5, 2022 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply...